🛳️Special Permits for Hazardous Materials Transportation Announced
In accordance with the procedures governing the application for, and the processing of, special permits from the Department of Transportation's Hazardous Material Regulations, notice is hereby given that the Office of Hazardous Materials Safety has received the application described herein.
Learn More📅Amended Notice of Meeting for National Human Genome Research Institute
This notice announces a change in the schedule for the National Advisory Council for Human Genome Research meeting, now set for June 18, 2025, and updates the link for virtual attendance. The meeting will be accessible both in person and online, ensuring public participation in discussions on human genome research.
Learn More📃Withdrawal of Proposed FAR Rule Affecting Small Business Innovation
OFPP, DoD, GSA, and NASA (collectively referred to as the Federal Acquisition Regulatory Council, or FAR Council) are withdrawing the proposed rule to amend the Federal Acquisition Regulation (FAR) titled: Small Business Innovation Research and Technology Transfer. The FAR Council will re-evaluate implementation following the finalization of the Revolutionary FAR Overhaul initiative. Accordingly, this proposed rule is withdrawn, and the FAR case is closed.
Learn More💰2025 Adjustment of Civil Monetary Penalties by HUD
This rule provides for 2025 inflation adjustments of civil monetary penalty amounts required by the Federal Civil Penalties Inflation Adjustment Act of 1990, as amended by the Federal Civil Penalties Inflation Adjustment Act Improvements Act of 2015 (the 2015 Act). This rule also removes an obsolete regulation relating to the imposition of civil monetary penalties.
Learn More📈Cboe EDGX Proposes Changes to Options Opening Process
Cboe EDGX Exchange proposes a new rule to automate the opening process for exclusively listed index options, enabling quicker market entry even without a Composite Market. This aims to enhance market efficiency, allowing participants to trade and manage their positions more effectively, thereby promoting a fair and orderly market.
Learn More🏞️USIBWC Adopts NASA's Categorical Exclusion for Property Transfers
Pursuant to section 109 of the National Environmental Policy Act (NEPA), USIBWC is adopting National Aeronautics and Space Administration's (NASA) Categorical Exclusion (4)(iv) for the transfer of real property administrative control to another Federal agency. This notice describes the proposed action for which USIBWC intends to use NASA's Categorical Exclusion and describes the consultation between the agencies.
Learn More💧Approval of Projects for Consumptive Water Use in Susquehanna Basin
This notice lists Approvals by Rule for projects by the Susquehanna River Basin Commission during the period set forth in DATES.
Learn More🚚Hazardous Materials Special Permits Regulatory Notice and Impact
In accordance with the procedures governing the application for, and the processing of, special permits from the Department of Transportation's Hazardous Material Regulations, notice is hereby given that the Office of Hazardous Materials Safety has granted or denied the application described herein.
Learn More💰NYSE Texas Fee Schedule Amendment for Exchange Traded Products
The NYSE Texas has proposed amendments to its Fee Schedule to introduce listing and annual fees for Exchange Traded Products (ETPs) and Structured Products. The changes aim to enhance competitiveness by aligning with fees from NYSE Arca and encouraging issuers to list products on the Exchange, thereby improving market conditions for investors.
Learn More🧬FDA Proposes Reclassification of Hematology Devices Affecting ISH Systems
The Food and Drug Administration (FDA) is proposing to reclassify in situ hybridization (ISH) test systems indicated for use with a corresponding approved oncology therapeutic product (product codes NYQ, MVD, OWE, and PNK) from class III (premarket approval) into class II (special controls), subject to premarket notification. FDA is also proposing a new device classification regulation, along with the special controls that FDA believes are necessary to provide a reasonable assurance of safety and effectiveness for this device type.
Learn More